Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | NT5E | P21589 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8509316 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL2636631 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL15263324 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL4436402 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL5182595 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL240028 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL1994115 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL9393256 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| Water SCHEMBL5144372 | 0.99 | HIF1A (0.42) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL7643809 | 0.90 | PYGL (0.38) | HIF1AADORA2AADORA2BLMNANT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004096138-A2 | [18F]-FURANOSYLPURINE DERIVATIVES AND USES THEREOF | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2004-11-11 | — | — | WO | claimed |
| US-20030068631-A1 | Method for the identification of synthetic cell-or tissue-specific transcriptional regulatory regions | BAYLOR COLLEGE OF MEDICINE | 2003-04-10 | — | — | US | claimed |
| US-6410228-B1 | DETERMINATING BINDING SITES | BAYLOR COLLEGE OF MEDICINE | 2002-06-25 | — | — | US | claimed |
| EP-1003911-A1 | METHOD FOR THE IDENTIFICATION OF SYNTHETIC CELL- OR TISSUE-SPECIFIC TRANSCRIPTIONAL REGULATORY REGIONS | Valentis Inc. (US) | 2000-05-31 | — | — | EP | claimed |
| WO-1999002737-A1 | METHOD FOR THE IDENTIFICATION OF SYNTHETIC CELL- OR TISSUE-SPECIFIC TRANSCRIPTIONAL REGULATORY REGIONS | VALENTIS, INC. (US) | 1999-01-21 | — | — | WO | claimed |
| US-7960536-B2 | Artificially generated promoter sequences for use in monitoring transcription factor binding; gene expression regulation | GENETRONICS, INC. (US) | 2011-06-14 | — | — | US | disclosed |
| EP-1963366-A4 | METHODS FOR CYCLIC NUCLEOTIDE DETERMINATION | PROMEGA CORP (US) | 2009-05-06 | — | — | EP | disclosed |
| EP-1963366-A2 | METHODS FOR CYCLIC NUCLEOTIDE DETERMINATION | PROMEGA CORPORATION (US) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007067557-A2 | METHODS FOR CYCLIC NUCLEOTIDE DETERMINATION | PROMEGA CORPORATION (US) | 2007-06-14 | — | — | WO | disclosed |
| US-20050164282-A1 | Synthetic cell-or tissue-specific transcriptional regulatory regions | INOVIO PHARMACEUTICALS, INC. | 2005-07-28 | — | — | US | disclosed |
| US-6699979-B2 | PREPARED VIA A STEREOSPECIFIC SN2 NUCLEOPHILIC ATTACK OF A PHOSPHODIESTER, OR PHOSPHOROTHIOATE, ON THE 3' POSITION OF A XYLONUCLEOTIDE; USEFUL IN ANTISENSE OR PROBE TECHNOLOGY | ISIS PHARMACEUTICALS, INC. | 2004-03-02 | — | — | US | disclosed |
| US-20030166285-A1 | Methods and compositions for genetically modifying primate bone marrow cells | VALERIO DOMENICO (NL) | 2003-09-04 | — | — | US | disclosed |
| EP-0355135-B1 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1993-08-04 | — | — | EP | disclosed |
| US-5212295-A | Monomers for preparation of oligonucleotides having chiral phosphorus linkages | ISIS PHARMACEUTICALS (US) | 1993-05-18 | — | — | US | disclosed |
| WO-1993008296-A1 | OLIGONUCLEOTIDES HAVING CHIRAL PHOSPHORUS LINKAGES | ISIS PHARMACEUTICALS, INC. (US) | 1993-04-29 | — | — | WO | disclosed |
| WO-1993007281-A1 | METHOD FOR GENETICALLY MODIFYING BONE MARROW CELLS OF PRIMATES, AND USEFUL CELLS THEREFOR THAT PRODUCE RECOMBINANT RETROVIRAL VECTORS | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 1993-04-15 | — | — | WO | disclosed |
| US-4997926-A | Viricides | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1991-03-05 | — | — | US | disclosed |
| EP-0355135-A4 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES. | SCRIPPS CLINIC RES (US) | 1990-04-09 | — | — | EP | disclosed |
| EP-0355135-A1 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1990-02-28 | — | — | EP | disclosed |
| WO-1989004662-A1 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-06-01 | — | — | WO | disclosed |